There are very little data on the polymorphisms and haplotypes of ERCC2 in different populations. A closer examination of ERCC2 is necessary, especially in the promoter region, in order to determine ...
Somatic mutations in the helicase-encoding ERCC2 gene are associated with response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive urothelial bladder carcinoma. Among 48 ...
Interim results from a multicenter clinical study of tislelizumab combined with gemcitabine and cisplatin as neoadjuvant therapy for patients with cT2-T4aN0M0 MIBC. This is an ASCO Meeting Abstract ...
To evaluate the relationship of genetic polymorphisms of ERCC2 and ERCC4 genes, both involved in nucleotide excision repair (NER), and the risk of breast cancer, a hospital-based case-control study ...
Prognostic value of breast cancer m-RNA transcripts (Ts) detection by RT-PCR in GCSF stimulated peripheral blood (PB) after adjuvant chemotherapy (ACT) in high-risk breast cancer patients (HRBCP) ...
A study published in JNCI found two out of 241 variants to be true associations. When the data from various studies associating DNA repair genes with cancer risk was combined, few of these variants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results